Cite
Xiao H, Li P, Li X, et al. Synthesis and Biological Evaluation of a Series of Bile Acid Derivatives as FXR Agonists for Treatment of NASH. ACS Med Chem Lett. 2017;8(12):1246-1251doi: 10.1021/acsmedchemlett.7b00318.
Xiao, H., Li, P., Li, X., He, H., Wang, J., Guo, F., Zhang, J., Wei, L., Zhang, H., Shi, Y., Hou, L., Shen, L., Chen, Z., Du, C., Fu, S., Zhang, P., Hao, F., Wang, P., Xu, D., Liang, W., Tian, X., Zhang, A., Cheng, X., Yang, L., Wang, X., Zhang, X., Li, J., & Chen, S. (2017). Synthesis and Biological Evaluation of a Series of Bile Acid Derivatives as FXR Agonists for Treatment of NASH. ACS medicinal chemistry letters, 8(12), 1246-1251. https://doi.org/10.1021/acsmedchemlett.7b00318
Xiao, Hualing, et al. "Synthesis and Biological Evaluation of a Series of Bile Acid Derivatives as FXR Agonists for Treatment of NASH." ACS medicinal chemistry letters vol. 8,12 (2017): 1246-1251. doi: https://doi.org/10.1021/acsmedchemlett.7b00318
Xiao H, Li P, Li X, He H, Wang J, Guo F, Zhang J, Wei L, Zhang H, Shi Y, Hou L, Shen L, Chen Z, Du C, Fu S, Zhang P, Hao F, Wang P, Xu D, Liang W, Tian X, Zhang A, Cheng X, Yang L, Wang X, Zhang X, Li J, Chen S. Synthesis and Biological Evaluation of a Series of Bile Acid Derivatives as FXR Agonists for Treatment of NASH. ACS Med Chem Lett. 2017 Oct 31;8(12):1246-1251. doi: 10.1021/acsmedchemlett.7b00318. eCollection 2017 Dec 14. PMID: 29259742; PMCID: PMC5733277.
Copy
Download .nbib